| 产品编号 | 图片 | CAS No. | 名称及描述 | 规格 | 价格 | 分子式 | 快速订购 |
|---|---|---|---|---|---|---|---|
| GC13471-10mg |
|
1350622-33-1 |
kb-NB77-78 - Glpbio |
0 | 需询价 | C18H25NO3Si | |
| GC13471-5mg |
|
1350622-33-1 |
kb-NB77-78 - Glpbio |
0 | 需询价 | C18H25NO3Si | |
| GC13470-5mg |
|
500-65-2 |
Rhapontigenin - Glpbio |
0 | 需询价 | C15H14O4 | |
| GC13470-20mg |
|
500-65-2 |
Rhapontigenin - Glpbio |
0 | 需询价 | C15H14O4 | |
| GC13470-10mg |
|
500-65-2 |
Rhapontigenin - Glpbio |
0 | 需询价 | C15H14O4 | |
| GC13469-50mg |
|
7491-74-9 |
Piracetam - Glpbio |
0 | 需询价 | C6H10N2O2 | |
| GC13468-10mM (in 1mL DMSO) |
|
501437-28-1 |
BI-D1870 - Glpbio |
0 | 需询价 | C19H23F2N5O2 | |
| GC13468-50mg |
|
501437-28-1 |
BI-D1870 - Glpbio |
0 | 需询价 | C19H23F2N5O2 | |
| GC13468-10mg |
|
501437-28-1 |
BI-D1870 - Glpbio |
0 | 需询价 | C19H23F2N5O2 | |
| GC13468-5mg |
|
501437-28-1 |
BI-D1870 - Glpbio |
0 | 需询价 | C19H23F2N5O2 | |
| GC13467-50mg |
|
173039-10-6 |
PMPA (NAALADase inhibitor) - Glpbio |
0 | 需询价 | C6H11O7P | |
| GC13467-10mg |
|
173039-10-6 |
PMPA (NAALADase inhibitor) - Glpbio |
0 | 需询价 | C6H11O7P | |
| GC13466-50mg |
|
530-78-9 |
Flufenamic acid - Glpbio |
0 | 需询价 | C14H10F3NO2 | |
| GC13465-1g |
|
14362-31-3 |
Chlorcyclizine (hydrochloride) - Glpbio |
0 | 需询价 | C18H21ClN2 • HCl | |
| GC13465-500mg |
|
14362-31-3 |
Chlorcyclizine (hydrochloride) - Glpbio |
0 | 需询价 | C18H21ClN2 • HCl | |
| GC13465-250mg |
|
14362-31-3 |
Chlorcyclizine (hydrochloride) - Glpbio |
0 | 需询价 | C18H21ClN2 • HCl | |
| GC13465-100mg |
|
14362-31-3 |
Chlorcyclizine (hydrochloride) - Glpbio |
0 | 需询价 | C18H21ClN2 • HCl | |
| GC13464-5mg |
|
1445879-21-9 |
GSK 2837808A - Glpbio |
0 | 需询价 | C31H25F2N5O7S | |
| GC13464-50mg |
|
1445879-21-9 |
GSK 2837808A - Glpbio |
0 | 需询价 | C31H25F2N5O7S | |
| GC13464-10mM (in 1mL DMSO) |
|
1445879-21-9 |
GSK 2837808A - Glpbio |
0 | 需询价 | C31H25F2N5O7S | |
小泰
|
010-60710855
|